Dr. Cole is a pediatric neuro-oncologist who has dedicated her career to translational and clinical research, combining her expertise in molecular pathology, cancer genomics, and developmental therapeutics to identify novel treatments for children with cancer.
Dr. MacFarland's research focuses on syndromes that predispose to cancer development in children and adolescents. She has initiated several individual and collaborative research projects, working in pediatric polyposis syndromes and Li-Fraumeni syndrome. She is uncovering novel genomic drivers of disease and identifying biomarkers of cancer onset and progression.
Working together as a national community of hospitals, healthcare organizations, researchers and clinicians, patients and families to identify the most important research questions that can reduce children’s suffering and support their healthy development.
Work in the Resnick and Storm Lab focuses on the cell signaling mechanisms of oncogenesis and tumor progression in brain tumors. The lab studies signaling cascades and alterations to elucidate the molecular and genetic underpinnings in order to develop targeted therapies. As co-directors of the Center for Data Driven Discovery in Biomedicine, Drs. Resnick and Storm lead a multidisciplinary team to build and support a scalable, patient-focused healthcare and educational discovery ecosystem.
Onwards and upwards: Last week's grand opening of the new Roberts Center for Pediatric Research coincided with a series of exciting news that suggest breakthroughs are on the horizon, and also give us a sense of how far research at Children's Hospital of Philadelphia has come.
Buckle your seatbelts because this has been a busy week for research news at Children's Hospital of Philadelphia. (It was also Teen Driver Safety Week, a topic we touched on with one of our blog posts earlier this week and in last week's In the News post.) Cancer research is hitting the accelerator with the release of the national Cancer